ロード中...
Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma
We developed an RNA sequencing-based pipeline to discover differentially expressed cell surface molecules in neuroblastoma that meet criteria for optimal immunotherapeutic target safety and efficacy. Here we show that GPC2 is a strong candidate immunotherapeutic target in this childhood cancer. We d...
保存先:
| 出版年: | Cancer Cell |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5600520/ https://ncbi.nlm.nih.gov/pubmed/28898695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2017.08.003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|